2017 EHA Annual Meeting Highlights
![]() |
Successful Reduction in Treatment Intensity in Patients with Advanced-stage Hodgkin Lymphoma
Peter Borchmann, MD Begin |
![]() |
Estimating the Efficacy of Novel Therapies in Classical Hodgkin Lymphoma
Paul Bröckelmann, MD Begin |
![]() |
Evaluating the Efficacy of Nivolumab with and without Brentuximab Vedotin: New Trial Results and Treating Rare Lymphoma Cases: Effective Strategies for NHLPH
Andreas Engert, MD Begin |
![]() |
The Clinical Impact of PET-guided Treatment in Advanced-stage Hodgkin Lymphoma
Andrea Gallamini, MD Begin |
![]() |
Overall Survival in Classical Hodgkin Lymphoma: Real-world Experiences in Kentucky
Hayder Saeed, MD Begin |
![]() |
Early Trial Results of Combination Therapy with Brentuximab Vedotin in Hodgkin Lymphoma are Very Promising
Anas Younes, MD Begin |